Stock TLSA TIZIANA LIFE SCIENCES PLC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Tiziana Life Sciences PLC Nasdaq

Equities

TLSA

US88875G1013

Biotechnology & Medical Research

Business Summary

Tiziana Life Sciences Ltd. is a United Kingdom-based clinical-stage biotechnology company. The Company develops transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for secondary progressive multiple sclerosis, Crohn's Disease and KRAS+ NSCLC. Its pipeline candidates include Foralumab (TZLS-401), Anti IL-6R mAb (TZLS-501) and Milciclib (TZLS-201). Foralumab (TZLS-401) is a fully human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn’s and neurodegenerative diseases. Its Anti IL-6R mAb (TZLS-501), a fully human mAb binds to both membrane-bound and soluble forms of IL-6R, an inflammatory cytokine driving chronic inflammation associated with autoimmune disease and cancer, reducing circulating levels of the IL-6 cytokine. Milciclib is a potent, small molecule inhibitor of multiple cyclin-dependent kinases (CDKs), tropomycinreceptor kinases and Src family kinases controlling cell growth and malignant progression of cancer.

Number of employees: 9

Managers

Managers TitleAgeSince
Gabriele Cerrone CEO
 Chief Executive Officer 52 11/98/11
Keeren Shah DFI
 Director of Finance/CFO 47 -
Vaseem Palejwala CTO
 Chief Tech/Sci/R&D Officer - 01/17/01
Matthew Davis COO
 Chief Operating Officer - 01/22/01
Paul Spencer IRC
 Investor Relations Contact - 01/22/01
William Clementi PRN
 Corporate Officer/Principal - 01/23/01

Members of the board

Members of the board TitleAgeSince
John Brancaccio BRD
 Director/Board Member 76 01/20/01
Willy Simon BRD
 Director/Board Member 72 01/15/01
Gabriele Cerrone CEO
 Chief Executive Officer 52 11/98/11

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 194,612,289 63,373,729 ( 32.56 %) 0 32.56 %

Shareholders

NameEquities%Valuation
Gabriele Cerrone
38.03 %
38,890,635 38.03 % 33 M $
Geode Capital Management LLC
0.2110 %
215,825 0.2110 % 181 509 $
HSBC Bank Plc
0.1606 %
164,226 0.1606 % 138 114 $
Morgan Stanley Capital Services LLC
0.1233 %
126,138 0.1233 % 106 082 $
Ausdal Financial Partners, Inc.
0.0545 %
55,700 0.0545 % 46 844 $
EWA LLC
0.0541 %
55,300 0.0541 % 46 507 $
Zhang Financial LLC
0.0509 %
52,060 0.0509 % 43 782 $
UBS Securities LLC
0.0305 %
31,244 0.0305 % 26 276 $
Bank of America, NA (Charlotte, North Carolina)
0.0212 %
21,686 0.0212 % 18 238 $
Barclays Bank Plc
0.0171 %
17,500 0.0171 % 14 718 $

Holdings

NameEquities%Valuation
ACCUSTEM SCIENCES, INC.
11.80%
 1,337,970 11.80% 445,544 $

Company contact information

Tiziana Life Sciences Ltd.

14/15 Conduit Street

W1S 2XJ, London

+

http://www.tizianalifesciences.com
address Tiziana Life Sciences PLC(TLSA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MODERNA, INC. Stock Moderna, Inc.
+33.63% 5.08TCr
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.09% 4.28TCr
LONZA GROUP AG Stock Lonza Group AG
+49.62% 4.2TCr
CELLTRION, INC. Stock Celltrion, Inc.
-4.96% 2.95TCr
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.18% 2.61TCr
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.95% 1.91TCr
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+8.61% 1.31TCr
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+28.31% 1.22TCr
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+24.73% 1.21TCr
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. TLSA Stock
  4. TLSA Stock
  5. Company Tiziana Life Sciences PLC
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW